Tus-Pharmaceutical Group Co., Ltd. (000590.SZ)
- Previous Close
6.41 - Open
6.24 - Bid 6.55 x --
- Ask 6.56 x --
- Day's Range
6.32 - 6.57 - 52 Week Range
4.80 - 11.25 - Volume
4,575,300 - Avg. Volume
9,070,957 - Market Cap (intraday)
1.571B - Beta (5Y Monthly) 0.15
- PE Ratio (TTM)
59.64 - EPS (TTM)
0.11 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Jun 21, 2013
- 1y Target Est
--
Tus-Pharmaceutical Group Co., Ltd. manufactures and sells Chinese patent medicines, chemical medicines, and health foods in China. The company offers Guhan health essences, Danzao oral liquids, Danhuang granules, and Yangxin Dingpalan granules. It also provides tonic health care, cardiovascular and cerebrovascular products, children's nutrition, cold products, heat-clearing, and detoxification products, etc. The company was formerly known as Tus-Guhan Group Corp.,Ltd. Tus-Pharmaceutical Group Co., Ltd. was founded in 1956 and is headquartered in Hengyang, China.
www.tuspharma.cn1,237
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: 000590.SZ
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 000590.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 000590.SZ
Valuation Measures
Market Cap
1.54B
Enterprise Value
1.44B
Trailing P/E
60.82
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.79
Price/Book (mrq)
2.12
Enterprise Value/Revenue
3.56
Enterprise Value/EBITDA
23.17
Financial Highlights
Profitability and Income Statement
Profit Margin
6.24%
Return on Assets (ttm)
0.77%
Return on Equity (ttm)
3.48%
Revenue (ttm)
404.65M
Net Income Avi to Common (ttm)
25.25M
Diluted EPS (ttm)
0.11
Balance Sheet and Cash Flow
Total Cash (mrq)
189.77M
Total Debt/Equity (mrq)
13.10%
Levered Free Cash Flow (ttm)
-64.34M
Company Insights: 000590.SZ
000590.SZ does not have Company Insights